Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
Nido Biosciences has raised $86.6M in total funding. The most recent round was Series B. The last funding was announced in May 2023.
Nido Biosciences's investors include Bessemer Venture Partners, Eli Lilly, 5AM Ventures, Abingworth, OUP (Osage University Partners).
Nido Biosciences is headquartered in Watertown, United States.
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
Nido Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nido Biosciences — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/nido-biosciences. Accessed September 12, 2026.
VCBacked. (2023). Nido Biosciences — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/nido-biosciences
{{cite web |title=Nido Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/nido-biosciences |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated